Training activity information
Details
Prepare a range of interpretative reports including somatic and germline variants for ovarian and breast tumours
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Local procedures for reporting
- Recommendations for follow up or further testing
- Follow up testing strategies
- Scientific and clinical terminology including nomenclature
- Communication of complex scientific information to the multidisciplinary team
- Best practice guidelines for reporting
- Recommendations for patient treatment and management, including approved therapeutics relevant to genomics findings, and clinical trials
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Analyse, interpret and prepare interpretive reports of clinically relevant findings for patients with lung, central nervous system (CNS), sarcoma tumours, and somatic and germline variants in ovarian and breast cancer. |
| # 3 |
Outcome
Evaluate the clinical significance of variants identified for ovarian and breast tumours using a range of bioinformatics tools following best practice guidelines. |
| # 7 |
Outcome
Describe the implications of the identification of somatic and germline variation in tumour samples for the patient and their family. |
| # 8 |
Outcome
Practice with relevant specialties for the diagnosis and treatment of cancer patients, and contribute to multidisciplinary team meetings. |